Expert panel endorse individualized beta-lactam dosing for acutely ill patients - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Expert panel endorse individualized beta-lactam dosing for acutely ill patients

International guidance supports concentration-guided dosing for selected acutely ill patients, with clinical cure showing the clearest benefit.

  • By

  • Doug Brunk

  • August 17, 2026

  • 7 min

Share

Original Source(s)

Expert panel endorse individualized beta-lactam dosing for acutely ill patients

  • by Doug Brunk

  • August 17, 2026

Related Content

Evaluating the Role of Treatment Accessibility in HIV-TB Co-Infection: A Comparative Approach Using Fractional-Order Modeling

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.